AVANOS MEDICAL, INC. 10-Q filing
Filed 2026-05-05 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001606498-26-000063
- Form type
- 10-Q
- CIK
- 0001606498
- Primary document
- https://www.sec.gov/Archives/edgar/data/1606498/000160649826000063/avns-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for AVANOS MEDICAL, INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $182.2M | - | - |
| Cost Of Revenue | $88.0M | - | - |
| Gross Profit | $94.2M | - | - |
| Operating Income | $8.9M | - | - |
| Net Income | $5.1M | - | - |
| Eps Basic | 0.11 | - | - |
| Eps Diluted | 0.11 | - | - |
| Cash And Equivalents | $65.6M | - | - |
| Total Assets | $1.1B | - | - |
| Total Liabilities | $268.0M | - | - |
| Shareholders Equity | $782.1M | - | - |
| Operating Cash Flow | $-12.3M | - | - |